{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:20:42Z","timestamp":1789399242086,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijrobp.2017.05.023","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T22:32:53Z","timestamp":1495492373000},"page":"111-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review"],"prefix":"10.1016","volume":"99","author":[{"given":"Hannah","family":"Buckley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-5898","authenticated-orcid":false,"given":"Thankamma","family":"Ajithkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.05.023_bib1","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-013-3198-9","article-title":"Neoadjuvant radiotherapy for rectal cancer: Meta-analysis of randomized controlled trials","volume":"20","author":"Rahbari","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.suronc.2014.10.003","article-title":"Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: A systematic review and meta-analysis","volume":"23","author":"Zhou","year":"2014","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijrobp.2017.05.023_bib3","first-page":"CD006041","article-title":"Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer","author":"De Caluwe","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0360-3016(00)00692-1","article-title":"Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: A phase II dose escalation study","volume":"48","author":"Chan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2010.03.008","article-title":"Evaluation of biologic effective dose and schedule of fractionation for preoperative radiotherapy for rectal cancer: Meta-analyses and meta-regression","volume":"80","author":"Viani","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijrobp.2005.08.012","article-title":"Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival","volume":"64","author":"Wiltshire","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","article-title":"Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis","volume":"113","author":"Burbach","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clon.2015.10.012","article-title":"Rectal radiotherapy\u2014Intensity-modulated radiotherapy delivery, delineation and doses","volume":"28","author":"Teoh","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib11","series-title":"The GEC ESTRO Handbook of Brachytherapy","first-page":"3","article-title":"Rectal cancer","author":"Sun Myint","year":"2014"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1259\/bjr.71.845.9691890","article-title":"The clinical radiobiology of brachytherapy","volume":"71","author":"Dale","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib13","series-title":"Preoperative High Dose Rate Brachytherapy for Rectal Cancer (IPG531)","year":"2015"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bjs.1800800749","article-title":"Anorectal function after preoperative intraluminal brachytherapy and colonic J pouch-anal anastomosis for rectal carcinoma","volume":"80","author":"Kusunoki","year":"1993","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/bjs.1800840923","article-title":"Anoabdominal rectal resection and colonic J pouch-anal anastomosis: 10 years' experience","volume":"84","author":"Kusunoki","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1096-9098(199706)65:2<76::AID-JSO2>3.0.CO;2-K","article-title":"Results of preoperative intraluminal brachytherapy combined with radical surgery for middle and lower rectal carcinomas","volume":"65","author":"Yanagi","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s005950050613","article-title":"The effectiveness of preoperative intraluminal brachytherapy in preventing wall penetration and nodal involvement of rectal carcinomas","volume":"30","author":"Yanagi","year":"2000","journal-title":"Surg Today"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ijrobp.2012.02.006","article-title":"Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: A randomized trial comparing two radiation doses","volume":"84","author":"Jakobsen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2014.05.023","article-title":"Long-term results of a randomized trial in locally advanced rectal cancer: No benefit from adding a brachytherapy boost","volume":"90","author":"Appelt","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2007.07.018","article-title":"High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: The Clatterbridge experience","volume":"19","author":"Sun Myint","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"Suppl. 2","key":"10.1016\/j.ijrobp.2017.05.023_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1463-1318.2010.02322.x","article-title":"Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?","volume":"12","author":"Sun Myint","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib22","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s10350-004-6455-y","article-title":"Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: Early results of a phase I\/II study","volume":"45","author":"Vuong","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5114\/jcb.2015.51402","article-title":"High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer","volume":"7","author":"Vuong","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brachy.2005.03.006","article-title":"High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: Technical aspects","volume":"4","author":"Vuong","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.clon.2007.07.006","article-title":"High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer","volume":"19","author":"Vuong","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ejso.2015.05.002","article-title":"Effect of preoperative treatment strategies on the outcome of patients with clinical T3, non-metastasized rectal cancer: A comparison between Dutch and Canadian expert centers","volume":"41","author":"Breugom","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib27","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/codi.12193","article-title":"Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer","volume":"15","author":"Hesselager","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib28","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1158\/1078-0432.CCR-04-2587","article-title":"A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods","volume":"11","author":"Zlobec","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cncr.21600","article-title":"The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy","volume":"106","author":"Zlobec","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.bjc.6604172","article-title":"Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy","volume":"98","author":"Zlobec","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib31","first-page":"S43","article-title":"Is neoadjuvant high dose rate endorectal brachytherapy (HDREBT) alone safe?","volume":"96","author":"Vuong","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.scrs.2010.01.009","article-title":"High dose rate endorectal brachytherapy for patients with curable rectal cancer","volume":"21","author":"Vuong","year":"2010","journal-title":"Semin Colon Rectal Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2005.07.969","article-title":"Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost","volume":"64","author":"Jakobsen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00384-007-0407-7","article-title":"A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: A phase II trial","volume":"23","author":"Jakobsen","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: A prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib36","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1080\/0284186X.2016.1235797","article-title":"Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy","volume":"55","author":"Hall","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib37","doi-asserted-by":"crossref","first-page":"e6487","DOI":"10.1097\/MD.0000000000006487","article-title":"Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer","volume":"96","author":"Zheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clon.2015.11.002","article-title":"Combination of novel agents with radiotherapy to treat rectal cancer","volume":"28","author":"Greenhalgh","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejca.2012.09.026","article-title":"Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis","volume":"49","author":"An","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"Rodel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijrobp.2006.05.047","article-title":"Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?","volume":"66","author":"Glynne-Jones","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/annonc\/mdl173","article-title":"Alternative clinical end points in rectal cancer\u2014Are we getting closer?","volume":"17","author":"Glynne-Jones","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2016.04.025","article-title":"Computed tomography-planned high-dose-rate brachytherapy for treating uterine cervical cancer","volume":"96","author":"Zolciak-Siwinska","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/bjs.8732","article-title":"Critical appraisal of the \u2018wait and see\u2019 approach in rectal cancer for clinical complete responders after chemoradiation","volume":"99","author":"Glynne-Jones","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/codi.13207","article-title":"Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A systematic review","volume":"18","author":"Ryan","year":"2016","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib47","first-page":"241","article-title":"Predicting complete response: Is there a role for non-operative management of rectal cancer?","volume":"6","author":"Yang","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2482-11-34","article-title":"The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery","volume":"11","author":"Bokkerink","year":"2011","journal-title":"BMC Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.9809","article-title":"Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)","volume":"102","author":"Verseveld","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0000000000000368","article-title":"Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: A meta-analysis of published studies","volume":"263","author":"Petrelli","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib51","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s10147-015-0822-7","article-title":"Predictive markers of chemoradiotherapy for rectal cancer: Comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy","volume":"20","author":"Suzuki","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1471-2407-14-241","article-title":"P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer","volume":"14","author":"Sim","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clcc.2015.05.014","article-title":"Biomarkers and molecular imaging as predictors of response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer","volume":"14","author":"Molinari","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.023_bib55","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2017.01.033","article-title":"Endorectal brachytherapy boost after external beam radiation therapy in elderly or medically inoperable patients with rectal cancer: Primary outcomes of the phase 1 HERBERT study","volume":"98","author":"Rijkmans","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617309446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617309446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T10:58:24Z","timestamp":1535799504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617309446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0360301617309446"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.023","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}